---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-004782"
form_type: "8-K"
ticker: "SHPH"
cik: "0001757499"
company_name: "Shuttle Pharmaceuticals Holdings, Inc."
filed_at: "2026-02-02T23:59:59+00:00"
generated_at: "2026-05-16T05:41:00.349450+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Shuttle extends interim CEO Cooper's consulting agreement through August 1, 2026

## Summary
- Extended consulting agreement with Number 2 Capital Corp. (owned by interim co-CEO Cooper) to August 1, 2026.
- Monthly compensation unchanged at $20,000; 40-hour work week.
- Amendment effective retroactively to September 11, 2025.
- Agreement can be terminated by either party upon 30 days' notice.
- Standard confidentiality and non-disclosure provisions included.

## SEC filing metadata
- accession: 0001493152-26-004782
- form_type: 8-K
- ticker: SHPH
- cik: 0001757499
- company_name: Shuttle Pharmaceuticals Holdings, Inc.
- filed_at: 2026-02-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757499/000149315226004782/0001493152-26-004782-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757499/000149315226004782/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-004782
- JSON: https://secwatch.observer/filing/0001493152-26-004782.json
- Plain text: https://secwatch.observer/filing/0001493152-26-004782.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.